Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 23, 2020
Pencil Beam Scanning Proton Therapy Case Selection for Paediatric Abdominal Neuroblastoma: Effects of Tumour Location and Bowel GasP S Lim, V Rompokos, N Bizzocchi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 29, 2024
A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk NeuroblastomaJ E Gains, A Patel, Yen-Ch'ing Chang, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2019
Radiotherapy practice for paediatric brain tumours across Europe and quality assurance initiatives: Current situation, international survey and future perspectivesTeresa de Rojas, Enrico Clementel, Jordi Giralt, et al.
EJNMMI Physics|March 29, 2022
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [<sup>177</sup>Lu]Lu-DOTATATEJavian C Malcolm, Nadia Falzone, Jennifer E Gains, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastomaJennifer E Gains, Veronica Moroz, Matthew D Aldridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
[131I]meta-iodobenzylguanidine and topotecan combination treatment of tumors expressing the noradrenaline transporterAnthony G McCluskey, Marie Boyd, Susan C Ross, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 21, 2010
Development of an electronic database for quality assurance of radiotherapy in the International Society of Paediatric Oncology (Europe) high risk neuroblastoma studyMark N Gaze, Tom Boterberg, Karin Dieckmann, et al.
Future Oncology (London, England)|March 9, 2013
Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastomaJennifer E Gains, Christopher Stacey, Ivan Rosenberg, et al.
Journal of Personalized Medicine|October 21, 2020
Personalisation of Molecular Radiotherapy through Optimisation of TheragnosticsLauraMay Davis, April-Louise Smith, Matthew D Aldridge, et al.
Nuclear Medicine Communications|April 1, 1994
Carrier-free 131I-meta-iodobenzylguanidine: comparison of production from meta-diazobenzylguanidine and from meta-trimethylsilylbenzylguanidineR J Mairs, M N Gaze, D G Watson, et al.
Pageof 14